The start-up specializing in artificial intelligence InstaDeep announced on Tuesday that it had raised 100 million dollars during a funding round which included the German laboratory BioNTech, to develop decision-making artificial intelligence.
The London-based company also plans to expand its geographic presence, particularly in the United States where it plans to expand in 2022. Among the investors in this Series B fundraising - the third round - also include Google and Deutsche Bahn.
Decision-making artificial intelligence “
goes beyond pattern recognition, in order to contribute to decision-making
” in sectors such as biotechnologies, logistics, transport or electronics, specifies the company in a press release .
Detect Covid-19 variants
InstaDeep had thus announced in mid-January that it had successfully developed and tested with BioNTech a system making it possible to “
detect and monitor the appearance and evolution of high-risk variants
” of Covid.
This system “
identified 90% of the variants put under surveillance by the WHO, on average two months before their report
” and also, during tests, “
detected
Omicron
as a high-risk variant the same day of the publication of its genetic sequence
”, assures the company on Tuesday in its press release.
InstaDeep adds that it regularly collaborates with Google and is working on a project to fully automate rail routing for Deutsche Bahn.
Founded in 2014, the company has offices in Paris, Tunis, Lagos, Dubai and Cape Town and has 170 employees.